Patents by Inventor Akemi Baba

Akemi Baba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9139658
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: December 23, 2010
    Date of Patent: September 22, 2015
    Assignee: SUMITOMO DAINIPPON PHARMA CO., LTD.
    Inventors: Toshihiro Noguchi, Akemi Baba, Mitsuharu Hanada
  • Patent number: 8287918
    Abstract: Lung cancer can be treated effectively by combination of amrubicin or a pharmaceutically acceptable salt thereof with cisplatin.
    Type: Grant
    Filed: December 14, 2009
    Date of Patent: October 16, 2012
    Assignee: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro Noguchi, Akemi Baba
  • Publication number: 20110104160
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: December 23, 2010
    Publication date: May 5, 2011
    Applicant: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro NOGUCHI, Akemi Baba, Mitsuharu Hanada
  • Patent number: 7879327
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: June 11, 2007
    Date of Patent: February 1, 2011
    Assignee: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro Noguchi, Akemi Baba, Mitsuharu Hanada
  • Publication number: 20100092579
    Abstract: Lung cancer can be treated effectively by combination of amrubicin or a pharmaceutically acceptable salt thereof with cisplatin.
    Type: Application
    Filed: December 14, 2009
    Publication date: April 15, 2010
    Applicant: DAINIPPON SUMITOMO PHARMA
    Inventors: Toshihiro NOGUCHI, Akemi Baba
  • Patent number: 7659257
    Abstract: Lung cancer can be treated effectively by combination of amrubicin or a pharmaceutically acceptable salt thereof with cisplatin.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: February 9, 2010
    Assignee: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro Noguchi, Akemi Baba
  • Patent number: 7449181
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: November 11, 2008
    Assignee: Sumitomo Pharmaceuticals Company Limited
    Inventors: Toshihiro Noguchi, Akemi Baba, Mitsuharu Hanada
  • Publication number: 20080031881
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: June 11, 2007
    Publication date: February 7, 2008
    Applicant: Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Toshihiro NOGUCHI, Akemi Baba, Mitsuharu Hanada
  • Patent number: 7091189
    Abstract: By using a combination of amrubicin or a pharmaceutically acceptable salt thereof with another medicament for treating lung cancer (irinotecan, vinorelbine, gemcitabine, etc.), it is intended to provide medicaments for treating lung cancer having an improved antitumor therapeutic effect on lung cancer and reduced side effects. Lung cancer can be effectively treated using these medicaments.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: August 15, 2006
    Inventors: Toshihiro Noguchi, Akemi Baba
  • Publication number: 20050119196
    Abstract: By using a combination of amrubicin or a pharmaceutically acceptable salt thereof with another medicament for treating lung cancer (irinotecan, vinorelbine, gemcitabine, etc.), it is intended to provide medicaments for treating lung cancer having an improved antitumor therapeutic effect on lung cancer and reduced side effects. Lung cancer can be effectively treated using these medicaments.
    Type: Application
    Filed: March 17, 2003
    Publication date: June 2, 2005
    Inventors: Toshihiro Noguchi, Akemi Baba
  • Publication number: 20040038913
    Abstract: Lung cancer can be treated effectively by combination of amrubicin or a pharmaceutically acceptable salt thereof with cisplatin.
    Type: Application
    Filed: July 17, 2003
    Publication date: February 26, 2004
    Inventors: Toshihiro Noguchi, Akemi Baba
  • Publication number: 20030157097
    Abstract: A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.
    Type: Application
    Filed: April 21, 2003
    Publication date: August 21, 2003
    Inventors: Toshihiro Noguchi, Akemi Baba, Mitsuharu Hanada